Skip to content

Stay informed

SeerPharma sends out a monthly newsletter, advising of new training programs and offers. If you would like to be added to our mailing list, click here.


Note: We use 128-bit SSL security encryption on all webpages where private information is taken.

Terms and conditions

Home

News and events

SeerPharma Events/Conferences

For SeerPharma country specific events, please click on the links in the top left bar for more information.

There are currently no events being held

If you can't find a suitable event, please feel free to make a suggestion to admin.singapore@seerpharma.com.au


SeerPharma News & Announcements

Latest Industry News

FDA

Tygacil (tigecycline): Label Change - Increased Mortality Risk
FDA seeks court order against Michigan dairy
FDA launches new organizational performance management system
Huber Needles: Recall - Risk of Coring
Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens
TimeOut Capsules: Undeclared Drug Ingredient
FDA Warns Consumers to Avoid TimeOut Capsules
MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient
Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events
FDA releases guidance on federal menu labeling requirements
FDA Warns of Possible Dangers from Portable Foot-Tanning Device
Mr. Magic Male Enhancer: Undeclared Drug Ingredient
INOMAX DS Drug-Delivery System: Class I Recall - Risk of Interruption of Drug Flow
Study: Presence of murine leukemia virus found in CFS Patients, others
Urgent Nationwide Frozen Mamey Fruit Products Recall

Medical Devices

Tygacil (tigecycline): Label Change - Increased Mortality Risk
Huber Needles: Recall - Risk of Coring
Fingerstick Devices to Obtain Blood Specimens: Initial Communication - Risk of Transmitting Bloodborne Pathogens
TimeOut Capsules: Undeclared Drug Ingredient
MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient
Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events
Mr. Magic Male Enhancer: Undeclared Drug Ingredient
INOMAX DS Drug-Delivery System: Class I Recall - Risk of Interruption of Drug Flow

Press Releases

FDA seeks court order against Michigan dairy
FDA launches new organizational performance management system
FDA Warns Consumers to Avoid TimeOut Capsules
FDA releases guidance on federal menu labeling requirements
FDA Warns of Possible Dangers from Portable Foot-Tanning Device
Study: Presence of murine leukemia virus found in CFS Patients, others
Urgent Nationwide Frozen Mamey Fruit Products Recall

Permalink
Site Designed By Vwin Media